First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol

J Dermatol. 2023 Apr;50(4):e123-e124. doi: 10.1111/1346-8138.16657. Epub 2022 Dec 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Atenolol / therapeutic use
  • Hemangioendothelioma* / diagnosis
  • Hemangioendothelioma* / drug therapy
  • Humans
  • Kasabach-Merritt Syndrome*
  • Propranolol / therapeutic use
  • Sarcoma, Kaposi* / diagnosis
  • Sarcoma, Kaposi* / drug therapy

Substances

  • Propranolol
  • Atenolol

Supplementary concepts

  • Kaposiform Hemangioendothelioma